Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies
Epilepsia ( IF 5.6 ) Pub Date : 2020-07-01 , DOI: 10.1111/epi.16573 Ivan Rektor 1 , Gregory L Krauss 2 , Yushi Inoue 3 , Sunao Kaneko 4 , Betsy Williams 5 , Anna Patten 6 , Manoj Malhotra 7 , Antonio Laurenza 5 , Robert T Wechsler 8
Epilepsia ( IF 5.6 ) Pub Date : 2020-07-01 , DOI: 10.1111/epi.16573 Ivan Rektor 1 , Gregory L Krauss 2 , Yushi Inoue 3 , Sunao Kaneko 4 , Betsy Williams 5 , Anna Patten 6 , Manoj Malhotra 7 , Antonio Laurenza 5 , Robert T Wechsler 8
Affiliation
This post hoc analysis evaluated long‐term efficacy and safety in patients with focal to bilateral tonic‐clonic seizures (FBTCS) or generalized tonic‐clonic seizures (GTCS) who entered open‐label extension (OLEx) studies to receive long‐term adjunctive perampanel.
中文翻译:
评估辅助 perampanel 在强直阵挛发作中的长期疗效和安全性:四项开放标签扩展研究的分析
这项事后分析评估了局灶性至双侧强直阵挛发作 (FBTCS) 或全身强直阵挛发作 (GTCS) 的长期疗效和安全性,这些患者进入开放标签扩展 (OLEx) 研究以接受长期辅助吡仑帕奈.
更新日期:2020-07-01
中文翻译:
评估辅助 perampanel 在强直阵挛发作中的长期疗效和安全性:四项开放标签扩展研究的分析
这项事后分析评估了局灶性至双侧强直阵挛发作 (FBTCS) 或全身强直阵挛发作 (GTCS) 的长期疗效和安全性,这些患者进入开放标签扩展 (OLEx) 研究以接受长期辅助吡仑帕奈.